HK1094531A1 - P185neu-encoding dna and therapeutical uses thereof - Google Patents

P185neu-encoding dna and therapeutical uses thereof

Info

Publication number
HK1094531A1
HK1094531A1 HK07101473.7A HK07101473A HK1094531A1 HK 1094531 A1 HK1094531 A1 HK 1094531A1 HK 07101473 A HK07101473 A HK 07101473A HK 1094531 A1 HK1094531 A1 HK 1094531A1
Authority
HK
Hong Kong
Prior art keywords
p185neu
encoding dna
therapeutical uses
therapeutical
dna
Prior art date
Application number
HK07101473.7A
Other languages
English (en)
Inventor
Augusto Amici
Federica Cavallo
Guido Forni
Cristina Marchini
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1094531A1 publication Critical patent/HK1094531A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK07101473.7A 2003-10-09 2007-02-08 P185neu-encoding dna and therapeutical uses thereof HK1094531A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001942A ITMI20031942A1 (it) 2003-10-09 2003-10-09 Dna codificante p185^neu e suoi usi terapeutici
PCT/EP2004/011161 WO2005039618A1 (en) 2003-10-09 2004-10-06 p185neu-ENCODING DNA AND THERAPEUTICAL USES THEREOF

Publications (1)

Publication Number Publication Date
HK1094531A1 true HK1094531A1 (en) 2007-04-04

Family

ID=34509441

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07101473.7A HK1094531A1 (en) 2003-10-09 2007-02-08 P185neu-encoding dna and therapeutical uses thereof

Country Status (20)

Country Link
US (3) US7795016B2 (xx)
EP (1) EP1670498B9 (xx)
JP (1) JP4829114B2 (xx)
KR (2) KR101215768B1 (xx)
CN (1) CN100546647C (xx)
AU (1) AU2004283430B2 (xx)
CA (1) CA2541840C (xx)
DK (1) DK1670498T3 (xx)
ES (1) ES2402767T3 (xx)
HK (1) HK1094531A1 (xx)
IL (1) IL174821A (xx)
IT (1) ITMI20031942A1 (xx)
NO (1) NO340097B1 (xx)
NZ (1) NZ546411A (xx)
PL (1) PL1670498T3 (xx)
PT (1) PT1670498E (xx)
RU (1) RU2350652C2 (xx)
SG (1) SG146693A1 (xx)
SI (1) SI1670498T1 (xx)
WO (1) WO2005039618A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031942A1 (it) * 2003-10-09 2005-04-10 Indena Spa Dna codificante p185^neu e suoi usi terapeutici
ITMI20041965A1 (it) * 2004-10-15 2005-01-15 Augusto Amici "dna codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici"
US20160038577A1 (en) * 2014-08-06 2016-02-11 Indena S.p.A. Con Socio Unico Use of anti-erbb2 vaccines in association with an electric field
CN116042649B (zh) * 2022-11-11 2023-07-21 河北省农林科学院棉花研究所（河北省农林科学院特种经济作物研究所） 一种编码富含半胱氨酸的非分泌型小分子肽及其编码基因与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239116B1 (en) * 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
KR100555211B1 (ko) 2002-07-16 2006-03-03 주식회사 팬제노믹스 항암효과를 갖는 Ｈｅｒ-２/ｎｅｕ ＤＮＡ 백신
ITMI20031942A1 (it) * 2003-10-09 2005-04-10 Indena Spa Dna codificante p185^neu e suoi usi terapeutici

Also Published As

Publication number Publication date
CA2541840C (en) 2013-07-09
IL174821A0 (en) 2006-08-20
US8298821B2 (en) 2012-10-30
AU2004283430B2 (en) 2010-08-05
JP2007508004A (ja) 2007-04-05
JP4829114B2 (ja) 2011-12-07
ITMI20031942A1 (it) 2005-04-10
KR20070004526A (ko) 2007-01-09
WO2005039618A1 (en) 2005-05-06
US7795016B2 (en) 2010-09-14
CN100546647C (zh) 2009-10-07
ES2402767T3 (es) 2013-05-08
CA2541840A1 (en) 2005-05-06
US20110245330A1 (en) 2011-10-06
PL1670498T3 (pl) 2013-07-31
NO340097B1 (no) 2017-03-13
EP1670498B1 (en) 2013-02-13
EP1670498A1 (en) 2006-06-21
EP1670498B9 (en) 2013-08-21
SI1670498T1 (sl) 2013-05-31
KR101226873B1 (ko) 2013-01-25
CN1863547A (zh) 2006-11-15
US8389494B2 (en) 2013-03-05
KR101215768B1 (ko) 2012-12-26
SG146693A1 (en) 2008-10-30
IL174821A (en) 2012-02-29
RU2006111336A (ru) 2007-10-20
US20110071212A1 (en) 2011-03-24
DK1670498T3 (da) 2013-03-11
KR20110125682A (ko) 2011-11-21
RU2350652C2 (ru) 2009-03-27
NO20061542L (no) 2006-04-05
PT1670498E (pt) 2013-04-15
NZ546411A (en) 2009-02-28
US20070299023A1 (en) 2007-12-27
AU2004283430A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
IL175491A0 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
AU2003290561A8 (en) Self-assembling arrays and uses thereof
EP1682136A4 (en) THERAPEUTIC COMPOUNDS AND CORRESPONDING USES THEREOF
HK1088837A1 (en) Clk-peptide and slk-peptide
GB0428391D0 (en) Connection and connection part
GB0326780D0 (en) Biological materials and uses thereof
GB0308382D0 (en) Therapeutic methods and means
GB0327384D0 (en) Gene therapy
HK1094531A1 (en) P185neu-encoding dna and therapeutical uses thereof
GB0318546D0 (en) Quinoxalinones and their use
HK1209050A1 (en) Survivin-derived peptides and use thereof
GB0300804D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0326778D0 (en) Biological materials and uses thereof
EP1487547A4 (en) MEDIUM FOR PHYSICAL INTERACTION AND ITS RELATED USES
GB0321694D0 (en) Genes and their therapeutic use
GB0301143D0 (en) Compounds and their use
EP1590432A4 (en) DNA COMPOSITION AND ITS USE
EP1602666A4 (en) NEW PROTEIN AND ITS DNA
GB0313625D0 (en) Therapeutic and assay methods
GB0321300D0 (en) Protein structure and uses thereof
AU2003211562A1 (en) Novel dna and use thereof
GB0321746D0 (en) Biological materials and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231006